[1] |
LIN Yi, WANG Ce, KANG Xun, KANG Zhuang, CHEN Feng, JIANG Bo, LI Wenbin.
Screening recurrent glioblastoma-related genes and analyzing their gene expressions in association with clinicopathological parameters and prognosis
[J]. China Oncology, 2022, 32(1): 13-23.
|
[2] |
XIAO Feng , XIAO Jingwen , SHAO Jianguo , CHEN Liyan , GU Chunyan .
The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis
[J]. China Oncology, 2021, 31(5): 419-427.
|
[3] |
NIU Na, LIN Yansong.
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
[J]. China Oncology, 2021, 31(5): 428-434.
|
[4] |
LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao .
Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6
[J]. China Oncology, 2021, 31(4): 268-276.
|
[5] |
ZHANG Jun , DONG Yuhua , YANG Ye , ZHANG Mengqi , HE Chang .
A novel strategy of regorafenib in combination with TAS102 against hepatocellular carcinoma
[J]. China Oncology, 2021, 31(4): 294-301.
|
[6] |
LI Zeng , WU Yi , CHEN Zhuzhong , CHEN Li , LIAO Hong , MAO Dun , XIAO Yingming , XIE Hongping , LI Xiuli , YANG Shengke , ZHOU Shukui , ZHONG Lei , LU Hao , CHEN Yongji .
The value of 18 F-PSMA-1007 PET/CT in the early diagnosis and clinical treatment of patients with biochemical recurrence after radical prostatectomy
[J]. China Oncology, 2021, 31(11): 1081-1087.
|
[7] |
ZHANG Xin , ZHOU Cheng , ZHOU Kaiqian , BAI Qianming , JIANG Dongxian , SUJIE Akesu , HOU Yingyong , WANG Zheng , JI Yuan .
MET gene amplification and its prognostic role in sarcomatoid hepatocellular carcinoma
[J]. China Oncology, 2020, 30(9): 641-649.
|
[8] |
XU Shanshan , SONG Qinqin , WU Hongjiao , FU Ning , CHE Lingyu , JIN Min , LIU Chong , HAN Sugui , ZHANG Xuemei , ZHANG Zhi .
Genetic variation in membrane cofactor protein CD46 rs1970530 affects the risk of hepatocellular carcinoma
[J]. China Oncology, 2020, 30(9): 656-660.
|
[9] |
LU Xiaoteng, XU Qing.
A study on factors associated with recurrence of non-small cell lung cancer based on CT image features
[J]. China Oncology, 2020, 30(8): 636-640.
|
[10] |
OUYANG Xiaochun , ZOU Yeqing , LI Yumei , DING Xiaobing .
ARHGAP4 promotes growth of hepatocellular carcinoma cells by regulating HK2 expression
[J]. China Oncology, 2020, 30(7): 481-487.
|
[11] |
PI Sidie, ZHENG Xiaochuan, MAO Binli, CUI Jing, HU Yuan.
SAMHD1 inhibits the proliferation of hepatocellular carcinoma by regulating the expression of p27
[J]. China Oncology, 2020, 30(7): 489-496.
|
[12] |
CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei .
Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score
[J]. China Oncology, 2020, 30(7): 505-511.
|
[13] |
DONG Baolong , HE Yu , CHEN Shiyong , WU Biao , GAO Peng , YANG Xiaojun .
Expression of KIF21B in hepatocellular carcinoma and its clinical significance
[J]. China Oncology, 2020, 30(5): 355-361.
|
[14] |
MENG Qiuhua, TIAN Jing, QIN Yan, MENG Qiuxiao, DONG Min.
The mechanism of protein tyrosine phosphatase receptor type delta affecting expression of PD-L1 in hepatocellular carcinoma via STAT3 pathway
[J]. China Oncology, 2020, 30(4): 261-267.
|
[15] |
FENG Zheng, WU Xiaohua.
Hematological toxicities of maintenance PARP inhibitors for patients with platinum-sensitive recurrent ovarian cancer
[J]. China Oncology, 2020, 30(4): 299-304.
|